Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 12, 2025
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
GlobeNewswire
·
May 12, 2025
MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from …
Best Cortisol Supplements 2025: CortiSync Under Review & Top Stress Relief Pills That Work
GlobeNewswire
·
May 12, 2025
Limassol, Cyprus, May 12, 2025 (GLOBE NEWSWIRE) -- Introduction: Best Supplements for High Cortisol 2025 – CortiSync Modern life is fast-paced, demanding, and filled with pressures that can take a toll on both the mind and body. At the center of this …
Services-Conseils en Ergonomie devient ERGOVIA
GlobeNewswire
·
May 12, 2025
SHERBROOKE, Québec, 12 mai 2025 (GLOBE NEWSWIRE) -- SCE Services-Conseils en Ergonomie devient ERGOVIA. Ce changement de nom s’accompagne d’une toute nouvelle image de marque. Cette évolution s'inscrit dans une démarche stratégique visant à mieux refléter …
Nurses Speak Out on Burnout, Balance, and the Future of the Profession in New Survey
GlobeNewswire
·
May 12, 2025
DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- While 75% of nurses report being satisfied with their career choice, many still face significant strain due to burnout, mental health challenges, and staffing issues, according to a new survey by AMN Healthcare, the …
InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease
GlobeNewswire
·
May 12, 2025
InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease Lille, May 12, 2025 – InBrain Pharma, a clinical stage biotech …
Porch Light Health Acquires Comprehensive Behavioral Health Center to Expand Access to Full-Spectrum Addiction Treatment
GlobeNewswire
·
May 12, 2025
DENVER, May 12, 2025 (GLOBE NEWSWIRE) -- Porch Light Health, the largest addiction medicine practice in Colorado, offering outpatient Medications for Addiction Treatment (MAT) at more than 60 treatment locations, is proud to announce the acquisition of …
Lancement de campagne de prévention au tabagisme chez les jeunes âgé·es de 11 à 15 ans : Laisse pas ta vie partir en fumée
GlobeNewswire
·
May 12, 2025
MONTRÉAL, 12 mai 2025 (GLOBE NEWSWIRE) -- Le RSEQ (Réseau du sport étudiant du Québec) lance Laisse pas ta vie partir en fumée, une campagne annuelle de prévention à l’initiation du tabagisme visant à sensibiliser les jeunes âgés de 11 à 15 ans. Elle vise …
Inspire Launches Patient Community Sponsorships, Offering Life Sciences Unprecedented Access to Condition-Specific, Engaged Populations
GlobeNewswire
·
May 12, 2025
Arlington, VA, May 12, 2025 (GLOBE NEWSWIRE) -- Inspire, the leading digital community platform for patients and caregivers across more than 3,000 conditions, today announced the launch of its Patient Community Sponsorship program. This new initiative …
Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M
GlobeNewswire
·
May 12, 2025
BOSTON, MASSACHUSETTS, May 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel antiviral therapies, today announced the successful completion of the dose optimization of its …
Brain Cancer Canada Grants McGill University $100,000 to Advance Pediatric Brain Cancer Research
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to award a $100,000 pediatric research grant to Dr. Carl Ernst, professor and scientist at McGill University, and his team. The work explores a gene therapy treatment for pediatric …
A Decade of Dapper: Movember and the Distinguished Gentleman’s Ride Gear Up to Celebrate 10 Years of Riding Together for Men’s Health
GlobeNewswire
·
May 12, 2025
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- A global movement with a decade of impact! This year, Movember and The Distinguished Gentleman’s Ride (DGR) proudly mark 10 years of partnership, riding to raise vital funds that lift the profile of men’s health …
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
GlobeNewswire
·
May 12, 2025
PORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
GlobeNewswire
·
May 12, 2025
Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin for the treatment of R/R …
ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer and Member of the Board of Directors
GlobeNewswire
·
May 12, 2025
Industry veteran brings over 30 years of experience driving technical, operational, and commercial excellence Has served as ElevateBio’s strategic advisor over the past year, working closely with the executive team to scale business and operations WALTHAM, …
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP
GlobeNewswire
·
May 12, 2025
May 12, 2025 Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted in 2019 Company nears start of Registrational Phase 3 …
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision
GlobeNewswire
·
May 12, 2025
SARASOTA, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced it will host a management update webinar on …
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
GlobeNewswire
·
May 12, 2025
Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies EDEN PRAIRIE, Minn., May 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a …
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
GlobeNewswire
·
May 12, 2025
CARMEL, Ind., May 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today …
Registration for 2025 World Astatine Community Meeting Now Open
GlobeNewswire
·
May 12, 2025
NEW ORLEANS, May 12, 2025 (GLOBE NEWSWIRE) -- The first-ever U.S.-based meeting of the World Astatine Community will take place June 19-20, 2025 at the Sheraton in downtown New Orleans. The event will highlight public and private sector research and …
Collegium Announces $25 Million Accelerated Share Repurchase Program
GlobeNewswire
·
May 12, 2025
STOUGHTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it …